Cargando…
Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report
BACKGROUND: As a debilitating syndrome, paraneoplastic cerebellar degeneration (PCD) remains challenging to treat. Further, anti-Yo antibody (directed against human cerebellar degeneration-related protein 2) detection in patients with PCD is associated with unsatisfactory responses to existing thera...
Autores principales: | Imai, Takeshi, Shinohara, Kensuke, Uchino, Kenji, Okuma, Hirohisa, Maki, Futaba, Hiruma, Kiyoshi, Ariizumi, Yasushi, Yamano, Yoshihisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059384/ https://www.ncbi.nlm.nih.gov/pubmed/35501715 http://dx.doi.org/10.1186/s12883-022-02684-4 |
Ejemplares similares
-
Anti-myelin Oligodendrocyte Glycoprotein Antibody-positive Myelitis after Coronavirus Disease 2019
por: Uchino, Kenji, et al.
Publicado: (2023) -
Paraneoplastic cerebellar degeneration with anti‐Yo antibodies – a review
por: Venkatraman, Anand, et al.
Publicado: (2016) -
Paraneoplastic Cerebellar Degeneration With P/Q-VGCC vs Yo
Autoantibodies
por: Winklehner, Michael, et al.
Publicado: (2022) -
Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity
por: Panja, D., et al.
Publicado: (2018) -
Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration: Case Series and Review of Literature
por: Chatham, Mathew, et al.
Publicado: (2021)